Brief: Vicore Pharma And HealthCap Create Drug Development Company Focused On Severe Lung Diseases

Vicore Pharma Holding AB

03/07/2018 07:37

July 3 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * VICORE PHARMA AND HEALTHCAP CREATE A LEADING DRUG
DEVELOPMENT
COMPANY FOCUSED ON SEVERE LUNG DISEASES
    * TO ACQUIRE INIM PHARMA AB ("INIM"), A SWEDISH
BIOPHARMACEUTICAL
COMPANY
    * HEALTHCAP OWNS 85 PERCENT OF INIM AND WILL HOLD ABOUT 30.4
PERCENT IN VICORE FOLLOWING TRANSACTION.
    * DECIDED TO PROPOSE A RIGHTS ISSUE OF APPROXIMATELY SEK 80
MILLION
    * AROUND 56.5 PERCENT OF RIGHTS ISSUE IS COVERED THROUGH
SUBSCRIPTION INTENTIONS AND UNDERTAKINGS.
    * PROPOSES THAT MAJORITY OF SHAREHOLDING IN I-TECH,
AMOUNTING TO
2,075,392 SHARES, IS DISTRIBUTED TO SHAREHOLDERS
    * GOAL IS TO INITIATE A PHASE II STUDY IN A SEVERE
INTERSTITIAL
LUNG DISEASE IN 2020.

Source text for Eikon:  ID:nWkr2wMVyF 
Further company coverage:  VICOR.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))